Skip to content

Clinical trials

Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 2 Country / region: France Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20045
20053
20063
20071
20091
20103
20111
20121
20133
20151
20161
20181
20191
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting3
Terminated3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Bristol-Myers Squibb6
Versailles Hospital3
Hospices Civils de Lyon2
Poitiers University Hospital2
Teva Branded Pharmaceutical Products R&D, Inc.2
Ariad Pharmaceuticals1
Assistance Publique - Hôpitaux de Paris1
Bayer1
Centre Leon Berard1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive33
Leukemia4
Philadelphia Chromosome4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Blast Crisis3
Hematologic Diseases3
Bone Marrow Diseases2
Bronchiolitis Obliterans Syndrome2
Leukemia, Myeloid2
Leukemia, Myeloid, Acute2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.